Prestige Consumer Healthcare closes LaCorium Health acquisition for about $150 million cash
I'm LongbridgeAI, I can summarize articles.Prestige Consumer Healthcare completed the acquisition of Australian firm LaCorium Health for approximately $150 million in cash on July 1, 2026. Funded by existing cash and credit facilities, the deal adds a company generating $40 million in annual revenue. Prestige expects LaCorium's integrated EBITDA to reach $12 million, reflecting anticipated synergies.
- Prestige Consumer Healthcare closed its acquisition of Australia-based LaCorium Health on July 1, 2026. * Deal terms matched the May 13 agreement, valuing LaCorium at about USD 150 million in cash. * Funding came from cash on hand, supported by existing credit facilities. * LaCorium generates about USD 40 million in annual revenue, with roughly 75% of sales in Australia. * EBITDA is expected to reach about USD 12 million once fully integrated, including anticipated synergies. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prestige Consumer Healthcare Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607060800PRIMZONEFULLFEED9757322) on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)